PFBT
TVTX icon

Parkside Financial Bank & Trust’s Travere Therapeutics TVTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11K Hold
71
– – ﹤0.01% 2098
2025
Q4 		$2.71K Hold
71
– – ﹤0.01% 1995
2025
Q3 		$1.7K Hold
71
– – ﹤0.01% 2085
2025
Q2 		$1.05K Buy
71
+11
+18% +$182 ﹤0.01% 2249
2025
Q1 		$1.08K Buy
+60
New +$1.22K ﹤0.01% 2078

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parkside Financial Bank & Trust's TVTX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Travere Therapeutics (TVTX) position steady in Q1 2026 at 71 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Parkside Financial Bank & Trust first reported a position in TVTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.71K in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Parkside Financial Bank & Trust held 71 shares of Travere Therapeutics worth $2.11K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Travere Therapeutics share count unchanged in Q1 2026.
  • Travere Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2098 holding.
  • Parkside Financial Bank & Trust first reported a position in Travere Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Travere Therapeutics position peaked at $2.71K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.